Cardiovascular changes in chronic renal failure--pathogenesis and therapy

K Amann1, K Tyralla

  • 1Institute for Pathology, University Erlangen-Nürnberg, Germany. kerstin.amann@patho.imed.uni-erlangen.de

Clinical Nephrology
|September 14, 2002
PubMed

Insights

Chronic renal failure patients face high cardiovascular mortality due to cardiac death from ischemia. Uremia causes heart and vessel changes, reducing myocardial ischemia tolerance and increasing mortality risk.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Pathology

Background:

  • Cardiac death due to ischemia is the primary cause of mortality in chronic renal failure (CRF) patients.
  • This ischemia is not always linked to coronary artery disease.
  • Uremia significantly impacts cardiac and vascular structures and function.

Purpose of the Study:

  • To review current findings on structural and functional changes in the heart and vessels of uremic patients.
  • To elucidate the mechanisms behind reduced myocardial ischemia tolerance in CRF.
  • To explain the high cardiovascular mortality observed in CRF.

Main Methods:

  • Review of existing literature on uremia-induced cardiovascular changes.
  • Analysis of structural alterations in the myocardium and vasculature.
  • Examination of metabolic changes affecting myocardial function.

Main Results:

  • Cardiovascular structural changes include left ventricular hypertrophy, interstitial fibrosis, and rarefaction of intramyocardial capillaries.
  • Myocardial microcirculation is affected by capillary rarefaction and thickening of intramyocardial arteries.
  • Metabolic changes, such as decreased high-energy phosphates, heighten myocardial ischemia sensitivity.
  • Extracardial vascular changes involve wall thickening, reduced elastic fibers, increased extracellular matrix, and media calcification, leading to increased vascular stiffness and reduced aortic compliance.

Conclusions:

  • Structural and functional cardiovascular changes in uremia significantly impair myocardial ischemia tolerance.
  • These changes contribute substantially to the high cardiovascular mortality in chronic renal failure.
  • Understanding these mechanisms is crucial for managing cardiovascular risk in CRF patients.

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...